Annual Working Capital
$612.44 M
-$125.31 M-16.99%
December 31, 2023
Summary
- As of February 7, 2025, MRVI annual working capital is $612.44 million, with the most recent change of -$125.31 million (-16.99%) on December 31, 2023.
- During the last 3 years, MRVI annual working capital has risen by +$411.62 million (+204.97%).
- MRVI annual working capital is now -16.99% below its all-time high of $737.76 million, reached on December 31, 2022.
Performance
MRVI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$615.86 M
-$953.00 K-0.15%
September 30, 2024
Summary
- As of February 7, 2025, MRVI quarterly working capital is $615.86 million, with the most recent change of -$953.00 thousand (-0.15%) on September 30, 2024.
- Over the past year, MRVI quarterly working capital has dropped by -$6.75 million (-1.08%).
- MRVI quarterly working capital is now -16.52% below its all-time high of $737.76 million, reached on December 31, 2022.
Performance
MRVI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
MRVI Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.0% | -1.1% |
| 3 y3 years | +205.0% | -1.1% |
| 5 y5 years | +3324.7% | -1.1% |
MRVI Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.0% | at low | -16.5% | +15.7% |
| 5 y | 5-year | -17.0% | +1876.3% | -16.5% | +556.5% |
| alltime | all time | -17.0% | +3324.7% | -16.5% | +556.5% |
Maravai LifeSciences Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $615.86 M(-0.2%) |
| Jun 2024 | - | $616.81 M(+1.3%) |
| Mar 2024 | - | $608.86 M(-0.6%) |
| Dec 2023 | $612.44 M(-17.0%) | $612.44 M(-1.6%) |
| Sep 2023 | - | $622.61 M(-0.3%) |
| Jun 2023 | - | $624.39 M(-2.5%) |
| Mar 2023 | - | $640.62 M(-13.2%) |
| Dec 2022 | $737.76 M | $737.76 M(+2.5%) |
| Sep 2022 | - | $719.87 M(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $646.85 M(+21.5%) |
| Mar 2022 | - | $532.46 M(-17.6%) |
| Dec 2021 | $646.26 M(+221.8%) | $646.26 M(+12.8%) |
| Sep 2021 | - | $573.13 M(+19.5%) |
| Jun 2021 | - | $479.72 M(+84.3%) |
| Mar 2021 | - | $260.29 M(+29.6%) |
| Dec 2020 | $200.82 M(+548.0%) | $200.82 M(-248.9%) |
| Sep 2020 | - | -$134.90 M(-535.3%) |
| Dec 2019 | $30.99 M(+73.3%) | $30.99 M |
| Dec 2018 | $17.88 M | - |
FAQ
- What is Maravai LifeSciences Holdings annual working capital?
- What is the all time high annual working capital for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual working capital year-on-year change?
- What is Maravai LifeSciences Holdings quarterly working capital?
- What is the all time high quarterly working capital for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly working capital year-on-year change?
What is Maravai LifeSciences Holdings annual working capital?
The current annual working capital of MRVI is $612.44 M
What is the all time high annual working capital for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual working capital is $737.76 M
What is Maravai LifeSciences Holdings annual working capital year-on-year change?
Over the past year, MRVI annual working capital has changed by -$125.31 M (-16.99%)
What is Maravai LifeSciences Holdings quarterly working capital?
The current quarterly working capital of MRVI is $615.86 M
What is the all time high quarterly working capital for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly working capital is $737.76 M
What is Maravai LifeSciences Holdings quarterly working capital year-on-year change?
Over the past year, MRVI quarterly working capital has changed by -$6.75 M (-1.08%)